东方生物 (688298.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(东方生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2021年一季报2020年年报2020年三季报2020年中报2020年一季报2019年年报2019年三季报2019年中报2019年一季报
主要指标:
 营业收入(元) 2,235,856,344.483,265,355,638.111,100,668,333.11828,150,045.54110,363,284.73367,376,821.29262,233,959.05169,686,760.35-
 营业利润(元) 1,377,376,219.571,974,346,165.06772,606,588.78605,768,807.3653,542,455.3291,033,632.5165,401,726.0637,318,403.89-
 利润总额(元) 1,377,374,378.971,974,281,458.82773,228,902.33606,316,888.4253,399,532.3791,297,017.4565,699,705.5137,592,557.08-
 净利润(元) 1,186,088,973.331,680,331,214.07664,212,634.38524,263,065.6345,662,622.0577,507,560.4155,135,753.7531,180,652.71-
 归属于母公司股东的净利润(元) 1,186,355,315.521,677,358,740.98664,456,764.88523,946,799.8543,916,037.4282,105,186.2458,352,937.1533,214,692.81-
盈利能力:
 销售毛利率(%) 75.3279.2483.0382.7763.2447.5147.0146.8145.17
 销售净利率(%) 53.0551.4660.3563.3141.3721.1021.0318.3814.35
 净资产收益率(%) 52.95124.3579.5769.64-----
 总资产报酬率ROA(%) 44.64103.2976.0262.26-----
 投入资本回报率ROIC(%) 39.02123.1277.2566.297.7630.9923.3313.17-
营运能力:
 存货周转率(次) 1.522.951.170.95-----
 应收账款周转率(次) 7.959.217.275.00-----
 总资产周转率(次) 0.741.661.050.85-----
偿债能力:
 资产负债率(%) 26.5931.3918.6119.6423.0629.7026.3134.78-
 股东权益比率(%) 73.2868.4581.2780.1976.5769.6372.4963.66-
 已获利息倍数(倍) -57.4335.1637.95-336.20-16.11-460.42-31.8529.95-
 流动比率 3.522.984.974.784.192.842.942.18-
 速动比率 3.012.614.083.913.631.901.861.42-
发展能力:
 营业收入增长率(%) 1,925.91788.83319.73388.0539.2128.5027.82--
 营业利润增长率(%) 2,472.492,068.811,081.321,523.24344.3921.1218.18--
 税后利润增长率(%) 2,601.421,942.941,038.691,477.45262.5225.6022.49--
 净资产增长率(%) 329.20871.70530.55542.68-25.22---
 总资产增长率(%) 348.46888.41462.49410.22-7.07---

前瞻产业研究院